When considering adjuvant chemotherapy for resected lung cancer, do you treat rarer histologic patterns such as acinar or lepidic the same as you would a more typical NSCLC?

Quick answer:

Lepidic histology can affect the decision for adjuvant therapy.

Acinar histology does not affect the decision for adjuvant therapy.

Rationale:

Lepidic is the AIS component in minimally invasive or invasive adenocarcinomas.

Based on Travis', JTO 2016, recommendation not to use the noninvasiv...